GAMMA Investing’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.4K Buy
3,190
+152
+5% +$3.56K ﹤0.01% 1980
2026
Q1
$42.6K Buy
3,038
+1,620
+114% +$21.8K ﹤0.01% 2287
2025
Q4
$15.9K Buy
1,418
+189
+15% +$2.16K ﹤0.01% 2734
2025
Q3
$14.2K Buy
1,229
+245
+25% +$2.87K ﹤0.01% 2698
2025
Q2
$12K Sell
984
-204
-17% -$2.56K ﹤0.01% 2716
2025
Q1
$17K Buy
1,188
+502
+73% +$7.84K ﹤0.01% 2482
2024
Q4
$10.9K Sell
686
-30
-4% -$594 ﹤0.01% 2560
2024
Q3
$17.2K Buy
716
+116
+19% +$2.65K ﹤0.01% 2194
2024
Q2
$12K Buy
600
+66
+12% +$1.28K ﹤0.01% 2148
2024
Q1
$10.6K Sell
534
-300
-36% -$5.8K ﹤0.01% 2028
2023
Q4
$16K Buy
+834
New +$17.2K ﹤0.01% 1643

Other funds holding AVNS

GAMMA Investing's AVNS Position: Q2 2026 in Review

GAMMA Investing increased its Avanos Medical (AVNS) stake by 5% in Q2 2026, buying an estimated $3.56K and bringing the position to 3,190 shares worth $79.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

GAMMA Investing first reported a position in AVNS in Q4 2023 and has held it in 11 quarters since. 26 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • GAMMA Investing held 3,190 shares of Avanos Medical worth $79.4K as of Q2 2026.
  • GAMMA Investing bought 152 Avanos Medical shares in Q2 2026, an estimated $3.56K.
  • Avanos Medical made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1980 holding.
  • GAMMA Investing first reported a position in Avanos Medical in Q4 2023 and has held it in 11 quarters since.
  • 26 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.